Raymond James & Associates’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$15.9M Buy
69,309
+43,946
+173% +$9.47M 0.01% 945
2024
Q2
$4.69M Buy
25,363
+1,497
+6% +$265K ﹤0.01% 1623
2024
Q1
$4.35M Sell
23,866
-19,663
-45% -$3.25M ﹤0.01% 1689
2023
Q4
$6.64M Sell
43,529
-82,147
-65% -$11.1M 0.01% 1347
2023
Q3
$15.8M Buy
125,676
+4,807
+4% +$656K 0.01% 791
2023
Q2
$19.1M Sell
120,869
-5,549
-4% -$774K 0.02% 715
2023
Q1
$16.1M Buy
126,418
+3,094
+3% +$427K 0.01% 782
2022
Q4
$17.4M Sell
123,324
-4,152
-3% -$490K 0.02% 732
2022
Q3
$11.2M Sell
127,476
-19,126
-13% -$1.98M 0.01% 897
2022
Q2
$14.8M Sell
146,602
-42,020
-22% -$5.26M 0.01% 760
2022
Q1
$27.3M Buy
188,622
+4,183
+2% +$578K 0.02% 561
2021
Q4
$23.9M Buy
184,439
+50,828
+38% +$6.53M 0.02% 656
2021
Q3
$18.5M Buy
133,611
+8,691
+7% +$1.32M 0.02% 755
2021
Q2
$18.3M Buy
124,920
+35,853
+40% +$5.42M 0.02% 757
2021
Q1
$11.9M Buy
89,067
+28,030
+46% +$3.72M 0.01% 926
2020
Q4
$8.39M Buy
61,037
+1,686
+3% +$210K 0.01% 1050
2020
Q3
$6.35M Buy
59,351
+4,739
+9% +$507K 0.01% 1097
2020
Q2
$5.07M Sell
54,612
-10,207
-16% -$1.02M 0.01% 1173
2020
Q1
$6.42M Sell
64,819
-57,246
-47% -$7.25M 0.01% 927
2019
Q4
$17.5M Buy
122,065
+2,975
+2% +$424K 0.02% 645
2019
Q3
$17.7M Buy
119,090
+54,502
+84% +$7.83M 0.02% 596
2019
Q2
$8.42M Buy
64,588
+5,043
+8% +$635K 0.01% 945
2019
Q1
$7.96M Sell
59,545
-5,461
-8% -$719K 0.01% 937
2018
Q4
$7.58M Buy
65,006
+7,676
+13% +$965K 0.01% 889
2018
Q3
$7.33M Buy
57,330
+4,780
+9% +$587K 0.01% 1005
2018
Q2
$5.86M Buy
52,550
+4,449
+9% +$521K 0.01% 1098
2018
Q1
$5.7M Sell
48,101
-25,884
-35% -$3.07M 0.01% 1075
2017
Q4
$8.39M Sell
73,985
-1,083
-1% -$116K 0.02% 857
2017
Q3
$8.33M Buy
75,068
+4,076
+6% +$459K 0.02% 840
2017
Q2
$8.67M Buy
70,992
+11,127
+19% +$1.32M 0.02% 772
2017
Q1
$7.45M Buy
59,865
+8,651
+17% +$1.02M 0.02% 830
2016
Q4
$5.45M Buy
51,214
+13,375
+35% +$1.58M 0.01% 946
2016
Q3
$4.66M Buy
37,839
+20,163
+114% +$2.55M 0.01% 986
2016
Q2
$2.37M Sell
17,676
-1,705
-9% -$225K 0.01% 1237
2016
Q1
$2.42M Buy
19,381
+950
+5% +$107K 0.01% 1176
2015
Q4
$2.2M Buy
18,431
+1,904
+12% +$233K 0.01% 1212
2015
Q3
$2.06M Buy
16,527
+449
+3% +$62.5K 0.01% 1203
2015
Q2
$2.29M Buy
+16,078
New +$2.01M 0.01% 1243
2015
Q1
Sell
-21,780
Closed -$2.42M 2405
2014
Q4
$2.42M Buy
21,780
+8,437
+63% +$886K 0.01% 1050
2014
Q3
$1.39M Sell
13,343
-19,826
-60% -$2.11M 0.01% 1297
2014
Q2
$3.18M Sell
33,169
-20,420
-38% -$1.76M 0.02% 850
2014
Q1
$4.4M Buy
53,589
+321
+0.6% +$25.8K 0.03% 637
2013
Q4
$4.33M Sell
53,268
-2,327
-4% -$186K 0.03% 586
2013
Q3
$4.17M Buy
55,595
+1,614
+3% +$113K 0.04% 546
2013
Q2
$3.62M Buy
+53,981
New +$3.57M 0.03% 553

Other funds holding UHS

Raymond James & Associates's UHS Position: Q3 2024 in Review

Raymond James & Associates increased its Universal Health Services (UHS) stake by 173% in Q3 2024, buying an estimated $9.47M and bringing the position to 69,309 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #945.

Raymond James & Associates first reported a position in UHS in Q2 2013 and has held it in 45 quarters since. The position peaked at $27.3M in Q1 2022. 619 funds tracked by Wall St. Rank hold UHS as of Q3 2024.

  • Raymond James & Associates held 69,309 shares of Universal Health Services worth $15.9M as of Q3 2024.
  • Raymond James & Associates bought 43,946 Universal Health Services shares in Q3 2024, an estimated $9.47M.
  • Universal Health Services made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #945 holding.
  • Raymond James & Associates first reported a position in Universal Health Services in Q2 2013 and has held it in 45 quarters since.
  • Raymond James & Associates's Universal Health Services position peaked at $27.3M in Q1 2022.
  • 619 funds tracked by Wall St. Rank held Universal Health Services as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.